Top

Published in:

01-05-2018 | Original Article

Transurethral vaporesection of prostate: diode laser or thulium laser?

Authors: Xinji Tan, Xiaobo Zhang, Dongjie Li, Xiong Chen, Yuanqing Dai, Jie Gu, Mingquan Chen, Sheng Hu, Yao Bai, Yu Ning

Published in: Lasers in Medical Science | Issue 4/2018

Abstract

This study compared the safety and effectiveness of the diode laser and thulium laser during prostate transurethral vaporesection for treating benign prostate hyperplasia (BPH). We retrospectively analyzed 205 patients with BPH who underwent a diode laser or thulium laser technique for prostate transurethral vaporesection from June 2016 to June 2017 and who were followed up for 3 months. Baseline characteristics of the patients, perioperative data, postoperative outcomes, and complications were compared. We also assessed the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Q_max), average flow rate (AFR), and postvoid residual volume (PVR) at 1 and 3 months postoperatively to evaluate the functional improvement of each group. There were no significant differences between the diode laser and thulium laser groups related to age, prostate volume, operative time, postoperative hospital stays, hospitalization costs, or perioperative data. The catheterization time was 3.5 ± 0.8 days for the diode laser group and 4.7 ± 1.8 days for the thulium laser group (p < 0.05). Each group had dramatic improvements in IPSS, QoL, Q_max, AFR, and PVR compared with the preoperative values (p < 0.05), although there were no significant differences between the two groups. Use of both diode laser and thulium laser contributes to safe, effective transurethral vaporesection in patients with symptomatic BPH. Diode laser, however, is better than thulium laser for prostate transurethral vaporesection because of its shorter catheterization time. The choice of surgical approach is more important than the choice of laser types during clinical decision making for transurethral laser prostatectomy.

Available only for authorised users

Zhang X, Zeng X, Liu Y, Dong L, Zhao X, Qu X (2014) Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int 93(2):214–219CrossRefPubMed

Yin Z, Yang JR, Rao JM, Song W, Zhou KQ (2015) Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. ASIAN J ANDROL 17(5):826–830PubMedPubMedCentral

He LY, Zhang YC, He JL, Li LX, Wang Y, Tang J, Tan J, Zhong K, Tang YX, Long Z (2016) The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention. ASIAN J ANDROL 18(1):134–139CrossRefPubMed

Nair SM, Pimentel MA, Gilling PJ (2016) A review of laser treatment for symptomatic BPH (benign prostatic hyperplasia). CURR UROL REP 17(6)

Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Assoc Urology Guidelines 2016*ed 2016:32

Takada J, Honda N, Hazama H, Ioritani N, Awazu K (2016) Analysis of thermally denatured depth in laser vaporization for benign prostatic hyperplasia using a simulation of light propagation and heat transfer (secondary publication). LASER THERAPY 25(4):273–284CrossRefPubMedPubMedCentral

Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2009) Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int 103(3):352–356CrossRefPubMed

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed

Long Z, Zhang YC, He LY, Zhong KB, Tang YX, Huang K (2014) Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia. ASIAN J SURG 37(2):58–64CrossRefPubMed

10.

Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12(3):277–280CrossRefPubMed

11.

Zhao Y, Liu C, Zhou G, Yu C, Zhang Y, Ouyang Y (2013) A retrospective evaluation of benign prostatic hyperplasia treatment by transurethral vaporization using a 1470 nm laser. Photomed Laser Surg 31(12):626–629CrossRefPubMed

12.

Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51CrossRefPubMed

13.

Kim Y, Seong YK, Kim IG, Han BH (2013) Twelve-month follow-up results of photoselective vaporization of the prostate with a 980-nm diode laser for treatment of benign hyperplasia. Korean J Urology 54(10):677CrossRef

14.

JIANG H, ZHOU Y (2016) Safety and efficacy of thulium laser prostatectomy versus transurethral resection of prostate for treatment of benign prostate hyperplasia: a meta-analysis. LUTS: Lower Urinary Tract Symptoms 8(3):165–170PubMed

15.

Lee WC, Lin YH, Hou CP, Chang PL, Chen CL, Juang HH, Tsui KH (2013) Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging 8:1483–1488PubMedPubMedCentral

16.

Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y (2009) High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 182(3):1078–1082CrossRefPubMed

17.

Barbalat Y, Velez MC, Sayegh CI, Chung DE (2016) Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction. Ther Adv Urol 8(3):181–191CrossRefPubMedPubMedCentral

18.

Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A (2014) Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology 84(3):526–532CrossRefPubMed

19.

Xu A, Zou Y, Li B, Liu C, Zheng S, Li H, Xu Y, Chen B, Xu K, Shen H (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27(10):1254–1260CrossRefPubMed

20.

Wang L, Yu QY, Liu Y, Zhu ZL, Huang YW, Li K (2016) Efficacy and safety of laser surgery and transurethral resection of the prostate for treating benign prostate hyperplasia: a network meta-analysis. Asian Pac J Cancer Prev 17(9):4281–4288PubMed

21.

Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R (2007) Diode laser. Ex vivo studies on vaporization and coagulation characteristics. Urologe A 46(9):1242–1247CrossRefPubMed

22.

Nafie S, Dormer J, Khan MA (2017) The significance of histological analysis following laser transurethral resection of the prostate. Int Urol Nephrol 49(8):1343–1346CrossRefPubMed

23.

Skinner T, Leslie RJ, Steele SS, Nickel JC (2017) Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia. Can Urol Assoc J 11(6):194–198CrossRefPubMedPubMedCentral

24.

Zhang X, Shen P, He Q, Yin X, Chen Z, Gui H, Shu K, Tang Q, Yang Y, Pan X, Wang J, Chen N, Zeng H (2016) Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. SCI REP-UK 6(1):23503CrossRef

25.

Peng M, Yi L, Wang Y (2016) Photoselective vaporization of the prostate vs plasmakinetic resection of the prostate: a randomized prospective trial with 12-month follow-up in mainland China. Urology 87:161–165CrossRefPubMed

26.

Li D, Jiang X, Zhang X, Yi L, Zhu X, Zeng X, Guo X, Tang Y (2012) Multicenter pathophysiologic investigation of erectile dysfunction in clinic outpatients in China. Urology 79(3):601–606CrossRefPubMed

Title: Transurethral vaporesection of prostate: diode laser or thulium laser?
Authors: Xinji Tan
Xiaobo Zhang
Dongjie Li
Xiong Chen
Yuanqing Dai
Jie Gu
Mingquan Chen
Sheng Hu
Yao Bai
Yu Ning
Publication date: 01-05-2018
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 4/2018
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-018-2499-4

At a glance: The STEP trials

Springer Medicine

Transurethral vaporesection of prostate: diode laser or thulium laser?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Effects of light-emitting diode irradiation on time to exhaustion at maximal aerobic speed

Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis

Muscle fiber conduction velocity and EMG amplitude of the upper trapezius muscle in healthy subjects after low-level laser irradiation: a randomized, double-blind, placebo-controlled, crossover study

Objective evaluation of the effects of intense pulsed light treatment on Asian skin by reflectance confocal microscopy analysis

Comparative efficacy of Er,Cr:YSGG and Er:YAG lasers for etching of composite for orthodontic bracket bonding

Case series about ex vivo identification of squamous cell carcinomas by laser-induced autofluorescence and Fourier transform infrared spectroscopy